Lynxiclav(Amoxicillin/Clavulanate Potassium Tablet 625Mg)
₦16,000.00
Lynxiclav 625 mg is a combination antibiotic that includes amoxicillin and clavulanate potassium. This formulation is designed to treat a variety of bacterial infections by leveraging the strengths of both components to combat resistant bacteria.
Key Features:
- Active Ingredients:
- Amoxicillin (500 mg): A broad-spectrum penicillin antibiotic that interferes with bacterial cell wall synthesis, leading to cell death.
- Clavulanate Potassium (125 mg): A beta-lactamase inhibitor that protects amoxicillin from degradation by certain bacteria, enhancing its effectiveness.
- Indications:
- Used to treat various infections, including:
- Respiratory tract infections (e.g., pneumonia, bronchitis)
- Urinary tract infections
- Skin and soft tissue infections
- Dental infections
- Sinusitis
- Used to treat various infections, including:
- Dosage Form:
- Available as tablets for oral administration.
Usage:
- Dosage:
- The dosage should be prescribed by a healthcare provider, commonly taken as one tablet every 12 hours for adults. Specific dosages may vary based on the type and severity of the infection.
- Administration:
- Take with a full glass of water, preferably with food to minimize gastrointestinal discomfort.
Precautions:
- Allergies:
- Inform your healthcare provider of any known allergies to penicillins, cephalosporins, or other antibiotics.
- Side Effects:
- Common side effects may include gastrointestinal disturbances (nausea, vomiting, diarrhea), skin rash, and allergic reactions. Report any severe or unusual side effects to your healthcare provider.
- Interactions:
- Discuss any other medications you are taking with your healthcare provider to avoid potential interactions, particularly with anticoagulants and other antibiotics.
Storage:
- Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.
- Very secured payment methods
- Shipping will be calculated on checkout
- Please note that price may increase due to exchange rate, ensure updated price before making payment
Dispensing supervised byPharm. Tope Kareem, B.PharmPCN Reg. 023669
Last updated 28 August 2026How we write and check this informationPCN Premises Licence LAG20247B39C9




